StockData
Pluri Inc. logo

Pluri Inc. (PLUR) company profile

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.92−0.06 (-6.62%)

Close on Nov 18, 2026Market cap $11.30MP/E –Yield –

About Pluri

Biological Products, (No Diagnostic Substances), SIC 2836

Pluri Inc. is a biotechnology company that develops cell-based products, therapeutics, and related technologies using a proprietary three-dimensional cell expansion platform. The company's automated platform expands human, animal, and plant cells within a synthetic scaffold to support scalable cell manufacturing. Its activities encompass cell therapy and immunotherapy programs, contract development and manufacturing organization services, regenerative aesthetics and longevity initiatives, and food technology and bio-farming applications. Product candidates include placenta-derived cell therapies such as PLX-PAD and PLX-R18, as well as an allogeneic immunotherapy platform using placental mucosal-associated invariant T cells for solid tumors.

The company operates an in-house, industrial-scale cell manufacturing facility functioning under Good Manufacturing Practice standards on a self-declared basis. Pluri maintains clinical development activities and regulatory engagements across the United States, Europe, and Israel, alongside operations supported by subsidiaries in Israel and Germany. Its principal executive offices are located in Haifa, Israel.

Summary of the business section of Pluri's latest annual report, written by StockData.

Company profile

Company

Legal name
Pluri Inc.
Founded
2001
Headquarters
Haifa, Israel
Address
Matam Advanced Technology Park, Building No. 5
Phone
972-74-710-7171
Employees
92, Jun 30, 2026
Industry
Biological Products, (No Diagnostic Substances)
Incorporated in
Nevada
Fiscal year ends
June 30
Auditor
Kesselman & Kesselman, Haifa, Israel

Stock & identifiers

Ticker
PLUR
Former tickers
PSTI until Jul 25, 2022
Exchange
Nasdaq
IPO date
Jun 30, 2003
Shares outstanding
12M, Sep 9, 2026
Public float
$15.19M, Dec 31, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-8 reverse, Apr 1, 2024; 1-for-10 reverse, Jul 25, 2019; 1-for-200 reverse, Nov 26, 2007
SEC CIK
1158780
CUSIP
72942G203
ISIN
US72942G2030
FIGI
BBG000DQX509
Share class FIGI
BBG001S8QJB7
LEI
529900OZKMF7JGZMYM81
EIN
98-0351734

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Yaky YanayChief Executive Officer, Director498,594
Liat ZaltsChief Financial Officer92,767
Alexandre Weinstein ManieuDirector2,090,900
Doron ShorrerDirector45,197
Eitan AjchenbaumDirector12,353
Zami AbermanDirector155,684
Rami Avraham LeviDirector18,967
Maital Shemesh-RasmussenDirector19,144
Pinhas Doron BirgerDirector19,178

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$1.50M$577.09K$326.88K$-489–
FY2024$741.48K$306.68K$492.37K$-406–
FY2023$2.63M-$238.00K$375.24K$-344–
FY2022$1.30M-$1.77M$608.21K$-2184–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsIncentive payOtherTotalvs. prior year
Yaky Yanay
CEO
$441.82K–$944.34K$81.50K$35.10K$1.50M+103%
Liat Zalts
CFO & Treasurer
$194.64K–$381.32K–$13.72K$589.68K–
Chen Franco-Yehuda
Former CFO
$231.36K$25.79K$43.75K$10.86K$15.13K$326.88K-34%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“of June 30, 2026, we employed a total of 92 full-time employees and 21 part-time employees, of whom 73 full-time employees and 14 part-time”

Corporate history

Events identified from SEC filings

DateEventDetails
Jul 13, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jan 22, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jul 3, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jan 21, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 27, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jul 23, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 31, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Oct 19, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Apr 25, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Oct 13, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jul 13, 2022Name changeName changed from PLURISTEM THERAPEUTICS INC to Pluri Inc.
Mar 25, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 15, 2019Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jan 9, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 11, 2009Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 28, 2007Name changeName changed from PLURISTEM LIFE SYSTEMS INC to PLURISTEM THERAPEUTICS INC
Dec 10, 2007ListingRegistration of securities on an exchange (Form 8-A)
May 24, 2007Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 15, 2007Late filingNotification of late filing
Feb 14, 2005Late filingNotification of late filing
May 17, 2004Late filingNotification of late filing
Nov 14, 2003Late filingNotification of late filing
Sep 29, 2003Late filingNotification of late filing
Jul 1, 2003Name changeName changed from AI SOFTWARE INC to PLURISTEM LIFE SYSTEMS INC
May 15, 2003Late filingNotification of late filing
Nov 15, 2002Late filingNotification of late filing
Jul 15, 2002ListingRegistration of securities on an exchange (Form 8-A)

See a number that looks wrong?